NL7502952A - Vast therapeutisch preparaat voor inwendig gebruik. - Google Patents

Vast therapeutisch preparaat voor inwendig gebruik.

Info

Publication number
NL7502952A
NL7502952A NL7502952A NL7502952A NL7502952A NL 7502952 A NL7502952 A NL 7502952A NL 7502952 A NL7502952 A NL 7502952A NL 7502952 A NL7502952 A NL 7502952A NL 7502952 A NL7502952 A NL 7502952A
Authority
NL
Netherlands
Prior art keywords
internal use
therapeutic preparation
solid therapeutic
solid
preparation
Prior art date
Application number
NL7502952A
Other languages
English (en)
Dutch (nl)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NL7502952A publication Critical patent/NL7502952A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
NL7502952A 1974-03-12 1975-03-12 Vast therapeutisch preparaat voor inwendig gebruik. NL7502952A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (fr) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
NL7502952A true NL7502952A (nl) 1975-09-16

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7502952A NL7502952A (nl) 1974-03-12 1975-03-12 Vast therapeutisch preparaat voor inwendig gebruik.

Country Status (12)

Country Link
US (1) US3976764A (fr)
JP (1) JPS5512411B2 (fr)
BE (1) BE826498A (fr)
CA (1) CA1054056A (fr)
CH (1) CH604719A5 (fr)
DE (1) DE2510620C2 (fr)
DK (1) DK142802B (fr)
ES (1) ES435500A1 (fr)
FR (1) FR2263744B1 (fr)
GB (1) GB1507521A (fr)
NL (1) NL7502952A (fr)
SE (1) SE409286B (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
JPS58501128A (ja) * 1981-07-15 1983-07-14 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 徐放性テオフイリン
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (fr) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
AU654143B2 (en) * 1990-06-25 1994-10-27 Du Pont Merck Pharmaceutical Company, The Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
AP1224A (en) 1998-03-19 2003-11-14 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
EP1245227A1 (fr) * 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
EA011215B1 (ru) * 2003-02-21 2009-02-27 Лек Фармасьютиклз Д.Д. Терапевтическая система, содержащая амоксициллин и клавулановую кислоту, плавающая капсула
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
JP2010502591A (ja) * 2006-09-04 2010-01-28 パナセア バイオテック リミテッド プログラム可能な浮揚性送達技術
WO2009087665A2 (fr) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Nouveau système d'administration de médicament à rétention gastrique
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
CA2767143A1 (fr) * 2009-07-06 2011-01-13 Kyorin Pharmaceutical Co., Ltd. Comprime ayant une structure creuse
EP2590633B1 (fr) 2010-07-05 2017-10-11 Jagotec AG Forme posologique
BR112014000773A8 (pt) * 2011-07-14 2017-10-03 Apet Holding B V Composições de nicotinamida e uso terapêutico das mesmas
EP2765998A1 (fr) 2011-10-11 2014-08-20 Ranbaxy Laboratories Limited Système de dosage de rétention gastrique et procédé de préparation de celui-ci
CA2879282C (fr) * 2012-07-16 2022-05-03 Hendrik Jan Cornelis Meijerink Systeme d'administration pharmacologique a retention gastrique
DK2719376T3 (en) 2012-10-12 2015-06-15 Omya Int Ag Gastroretentiv drug formulation and delivery systems and their method of preparation by the use of functional calcium carbonate
EP3155024B1 (fr) 2014-06-11 2020-09-16 Massachusetts Institute Of Technology Structures rétentifs et procédés associés
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (fr) 2014-12-18 2016-06-22 Omya International AG Procédé pour la production d'un système d'administration pharmaceutique
EP3069713A1 (fr) 2015-03-20 2016-09-21 Omya International AG Forme posologique dispersible
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
JP2018515476A (ja) 2015-05-01 2018-06-14 マサチューセッツ インスティテュート オブ テクノロジー 誘発性形状記憶誘導デバイス
AU2016342374B2 (en) 2015-10-23 2022-08-04 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
US11992552B2 (en) 2015-12-08 2024-05-28 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
WO2017158171A1 (fr) * 2016-03-18 2017-09-21 Grünenthal GmbH Forme pharmaceutique flottante
EP3269361A1 (fr) 2016-07-14 2018-01-17 Omya International AG Forme posologique
CN110022861B (zh) 2016-09-30 2024-06-28 林德拉治疗公司 用于金刚烷类药物缓释的胃驻留系统
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
WO2021176360A1 (fr) * 2020-03-02 2021-09-10 Craft Health Pte Ltd Formes galéniques orales pour la libération prolongée d'un médicament
WO2023166225A1 (fr) * 2022-03-04 2023-09-07 APET Holding B.V. Formulations d'enzyme digestive

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
CA1054056A (fr) 1979-05-08
ES435500A1 (es) 1977-02-01
CH604719A5 (fr) 1978-09-15
DE2510620C2 (de) 1984-01-05
GB1507521A (en) 1978-04-19
JPS50121418A (fr) 1975-09-23
DK97875A (fr) 1975-09-13
DE2510620A1 (de) 1975-09-18
DK142802B (da) 1981-02-02
FR2263744A1 (fr) 1975-10-10
SE409286B (sv) 1979-08-13
FR2263744B1 (fr) 1978-11-24
JPS5512411B2 (fr) 1980-04-02
US3976764A (en) 1976-08-24
BE826498A (fr) 1975-06-30
SE7502725L (fr) 1975-09-15
DK142802C (fr) 1981-09-21

Similar Documents

Publication Publication Date Title
NL7502952A (nl) Vast therapeutisch preparaat voor inwendig gebruik.
SE427752B (sv) Forfarande for framstellning n-fosfonometylglycin
SE7507414L (sv) Galenisk beredning.
NL7514012A (nl) Farmaceutische capsules.
NL7511598A (nl) Voorgaren en werkwijze voor het vervaardigen ervan.
NL7510478A (nl) Werkwijze voor de bereiding van multiheteromacro- ringverbindingen.
NL7500552A (nl) Farmaceutische preparaten.
NL7507298A (nl) Werkwijze voor de bereiding van terpolymeren.
NL7402008A (nl) Voorbehoedmiddel.
NL7508829A (nl) Werkwijze voor de bereiding van aldehyden.
NL7505240A (nl) Farmaceutisch preparaat.
NL7503055A (nl) Werkwijze ter bereiding van therapeutische preparaten.
BE836826A (fr) Automatische modulatiebandegalisator voor datatransmissiesystemen
NO146199C (no) Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid
BE824750A (nl) Identificatibrand voor koeien
BE836589A (fr) Signaalverdeelinrichting voor een kabeltelevisienetwerk
NL7611088A (nl) N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan.
NL7500600A (nl) Voedselbereidingsinrichting voor huishoudelijk gebruik.
NL7500305A (nl) Werkwijze voor de bereiding van poly-alkeen- llietaatimiden.
BE820781A (fr) Deksels voor houders
BE830726A (nl) Lokmiddel voor mieren
NL7505174A (nl) Farmaceutische mengsels.
BE812477A (fr) Inspektieput voor rioleringssystemen
NL7312095A (nl) Inrichting voor ademhalingsonderzoek.
NL7512624A (nl) Werkwijze voor de octeennitrileverbindingen.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed